Cargando…

Validation of living with chronic illness scale in a type 2 diabetes mellitus population

BACKGROUND: Worldwide, type 2 diabetes mellitus (T2DM) is one of the most prevalent chronic diseases and one of those producing greatest impact on patients’ day-to-day quality of life. Our study aim is to validate the “Living with Chronic Illness Scale” for a Spanish-speaking T2DM population. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Caro-Bautista, Jorge, Rodríguez-Blázquez, Carmen, Perez-Manchon, David, Timonet-Andreu, Eva, Carvajal-Carrascal, Gloria, Fuentes-Ramírez, Alejandra, Corchon, Silvia, Aranda-Gallardo, Marta, Ambrosio, Leire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972215/
https://www.ncbi.nlm.nih.gov/pubmed/33731142
http://dx.doi.org/10.1186/s12955-021-01715-x
_version_ 1783666681060524032
author Caro-Bautista, Jorge
Rodríguez-Blázquez, Carmen
Perez-Manchon, David
Timonet-Andreu, Eva
Carvajal-Carrascal, Gloria
Fuentes-Ramírez, Alejandra
Corchon, Silvia
Aranda-Gallardo, Marta
Ambrosio, Leire
author_facet Caro-Bautista, Jorge
Rodríguez-Blázquez, Carmen
Perez-Manchon, David
Timonet-Andreu, Eva
Carvajal-Carrascal, Gloria
Fuentes-Ramírez, Alejandra
Corchon, Silvia
Aranda-Gallardo, Marta
Ambrosio, Leire
author_sort Caro-Bautista, Jorge
collection PubMed
description BACKGROUND: Worldwide, type 2 diabetes mellitus (T2DM) is one of the most prevalent chronic diseases and one of those producing greatest impact on patients’ day-to-day quality of life. Our study aim is to validate the “Living with Chronic Illness Scale” for a Spanish-speaking T2DM population. METHODS: In this observational, international, cross-sectional study, 582 persons with T2DM were recruited in primary care and outpatient hospital consultations, in Spain and Colombia, during the period from May 2018 to June 2019. The properties analysed were feasibility/acceptability, internal consistency, reliability, precision and (structural) content-construct validity including confirmatory factor analysis. The COSMIN checklist was used to assess the methodological/psychometric quality of the instrument. RESULTS: The scale had an adequate internal consistency and test retest reliability (Cronbach’s alpha = 0.90; intraclass correlation coefficient = 0.96, respectively). In addition, the instrument is precise (standard error of measurement = 3.34, with values < ½SD = 8.52) and correlates positively with social support (DUFSS) (r(s) = 0.56), quality of life (WHOQOL-BREF) (r(s) = 0.51–0.30) and ssatisfaction with life (SLS-6) (r(s) = 0.50–0.38). The original 26-items version of the scale did not support totally the confirmatory factor analysis. The COSMIN checklist is favourable for all the properties analysed, although weaknesses are detected for structural validity. CONCLUSIONS: The LW-CI-T2DM is a valid, reliable and accurate instrument for use in clinical practice to determine how a person’s life is affected by the presence of diabetes. This instrument correlates well with the associated constructs of social support, quality of life and satisfaction. Additional research is needed to determine how well the questionnaire structure performs when robust factor analysis methods are applied. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-021-01715-x.
format Online
Article
Text
id pubmed-7972215
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79722152021-03-19 Validation of living with chronic illness scale in a type 2 diabetes mellitus population Caro-Bautista, Jorge Rodríguez-Blázquez, Carmen Perez-Manchon, David Timonet-Andreu, Eva Carvajal-Carrascal, Gloria Fuentes-Ramírez, Alejandra Corchon, Silvia Aranda-Gallardo, Marta Ambrosio, Leire Health Qual Life Outcomes Research BACKGROUND: Worldwide, type 2 diabetes mellitus (T2DM) is one of the most prevalent chronic diseases and one of those producing greatest impact on patients’ day-to-day quality of life. Our study aim is to validate the “Living with Chronic Illness Scale” for a Spanish-speaking T2DM population. METHODS: In this observational, international, cross-sectional study, 582 persons with T2DM were recruited in primary care and outpatient hospital consultations, in Spain and Colombia, during the period from May 2018 to June 2019. The properties analysed were feasibility/acceptability, internal consistency, reliability, precision and (structural) content-construct validity including confirmatory factor analysis. The COSMIN checklist was used to assess the methodological/psychometric quality of the instrument. RESULTS: The scale had an adequate internal consistency and test retest reliability (Cronbach’s alpha = 0.90; intraclass correlation coefficient = 0.96, respectively). In addition, the instrument is precise (standard error of measurement = 3.34, with values < ½SD = 8.52) and correlates positively with social support (DUFSS) (r(s) = 0.56), quality of life (WHOQOL-BREF) (r(s) = 0.51–0.30) and ssatisfaction with life (SLS-6) (r(s) = 0.50–0.38). The original 26-items version of the scale did not support totally the confirmatory factor analysis. The COSMIN checklist is favourable for all the properties analysed, although weaknesses are detected for structural validity. CONCLUSIONS: The LW-CI-T2DM is a valid, reliable and accurate instrument for use in clinical practice to determine how a person’s life is affected by the presence of diabetes. This instrument correlates well with the associated constructs of social support, quality of life and satisfaction. Additional research is needed to determine how well the questionnaire structure performs when robust factor analysis methods are applied. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-021-01715-x. BioMed Central 2021-03-17 /pmc/articles/PMC7972215/ /pubmed/33731142 http://dx.doi.org/10.1186/s12955-021-01715-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Caro-Bautista, Jorge
Rodríguez-Blázquez, Carmen
Perez-Manchon, David
Timonet-Andreu, Eva
Carvajal-Carrascal, Gloria
Fuentes-Ramírez, Alejandra
Corchon, Silvia
Aranda-Gallardo, Marta
Ambrosio, Leire
Validation of living with chronic illness scale in a type 2 diabetes mellitus population
title Validation of living with chronic illness scale in a type 2 diabetes mellitus population
title_full Validation of living with chronic illness scale in a type 2 diabetes mellitus population
title_fullStr Validation of living with chronic illness scale in a type 2 diabetes mellitus population
title_full_unstemmed Validation of living with chronic illness scale in a type 2 diabetes mellitus population
title_short Validation of living with chronic illness scale in a type 2 diabetes mellitus population
title_sort validation of living with chronic illness scale in a type 2 diabetes mellitus population
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972215/
https://www.ncbi.nlm.nih.gov/pubmed/33731142
http://dx.doi.org/10.1186/s12955-021-01715-x
work_keys_str_mv AT carobautistajorge validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation
AT rodriguezblazquezcarmen validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation
AT perezmanchondavid validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation
AT timonetandreueva validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation
AT carvajalcarrascalgloria validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation
AT fuentesramirezalejandra validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation
AT corchonsilvia validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation
AT arandagallardomarta validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation
AT ambrosioleire validationoflivingwithchronicillnessscaleinatype2diabetesmellituspopulation